PMID: 1201446Dec 1, 1975Paper

Drug therapy in mental handicap

The British Journal of Psychiatry : the Journal of Mental Science
B Kirman

Abstract

Definitions of mental handicap are imprecise in practice, and a wide spectrum of patients are provided for under this heading. There can be no question of specific treatment for 'mental handicap' as such. Many situations arising in institutions for the mentally handicapped derive from the nature of the institution and the regime. Drugs may be used 'faute de mieux' when environmental manipulation would be more appropriate. There is much over-prescribing, and the choice of drugs is not always logical; monitoring of dose is seldom employed. A major source of behaviour disturbance in the mentally handicapped is lack of suitable occupation. Apart from a few specific indications, use of sedatives and tranquillizers for the mentally handicapped should be seen as a holding device, to enable a different system of management to be adopted or to disrupt an undesirable behaviour pattern.

References

Oct 1, 1974·The British Journal of Psychiatry : the Journal of Mental Science·D A Spencer
Oct 1, 1954·The Journal of Mental Science·K A YONGE, N O'CONNOR
Oct 1, 1957·The Journal of Mental Science·M CRAFT
Mar 1, 1965·The British Journal of Psychiatry : the Journal of Mental Science·J H CASTELL, P J MITTLER
Sep 2, 1967·British Medical Journal·T McKeown, I Leck

❮ Previous
Next ❯

Citations

May 1, 1979·Comprehensive Psychiatry·J Tu, J T Smith
Jan 1, 1989·Research in Developmental Disabilities·A H Reid
Apr 17, 1976·British Medical Journal
Aug 1, 1995·Journal of Intellectual Disability Research : JIDR·C KiernanA Alborz
Dec 1, 1978·Tsurumi shigaku. Tsurumi University dental journal·K Ohno, Y Sakamoto
Apr 1, 1979·Acta Psychiatrica Scandinavica·H Dyggve, T Kodahl
Nov 16, 2004·Research in Developmental Disabilities·Jane A McGillivray, Marita P McCabe
Jun 1, 1987·Australian Paediatric Journal·P J Foreman, J Ward
Nov 1, 1981·Child: Care, Health and Development·C Cunningham, K McArthur
Apr 1, 1986·Acta Psychiatrica Scandinavica·J Lund
Feb 1, 1991·The British Journal of Psychiatry : the Journal of Mental Science·T W Fan
Jul 1, 1990·The British Journal of Psychiatry : the Journal of Mental Science·S E WressellT P Berney
Apr 1, 1987·The British Journal of Psychiatry : the Journal of Mental Science·L C SheppardG W Fenton
Feb 1, 1983·The British Journal of Psychiatry : the Journal of Mental Science·D H James
Feb 1, 1989·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·P SidounR Elie
Aug 1, 1989·Journal of Mental Deficiency Research·S GaneshV A Cowie
Jun 1, 1987·Developmental Medicine and Child Neurology·E BeghiE Manghi
Feb 1, 1994·Journal of Intellectual Disability Research : JIDR·K Gingell, J Nadarajah
Feb 1, 1989·Journal of Mental Deficiency Research·J M RaoB Mathew

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The British Journal of Psychiatry : the Journal of Mental Science
D H James
The British Journal of Psychiatry : the Journal of Mental Science
S E WressellT P Berney
Journal of Behavior Therapy and Experimental Psychiatry
M A Bluestone
© 2022 Meta ULC. All rights reserved